738 related articles for article (PubMed ID: 2666885)
41. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
Zárate A; Canales ES; Alger M; Forsbach G
Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
[TBL] [Abstract][Full Text] [Related]
42. Giant invasive prolactinoma: a case report and review of nine further cases.
Davis JR; Sheppard MC; Heath DA
Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
[TBL] [Abstract][Full Text] [Related]
43. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
[TBL] [Abstract][Full Text] [Related]
44. [Bromocriptine treatment of hyperprolactinemia].
Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
[TBL] [Abstract][Full Text] [Related]
45. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
[TBL] [Abstract][Full Text] [Related]
46. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
Tan SL; Jacobs HS
Int J Gynaecol Obstet; 1986 Jun; 24(3):209-15. PubMed ID: 2880760
[TBL] [Abstract][Full Text] [Related]
47. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
[TBL] [Abstract][Full Text] [Related]
48. [Bromocriptine therapy of prolactinoma in pregnancy].
Nehmzow M; Ventz M; Meng W
Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
50. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.
Colao A; Loche S; Cappa M; Di Sarno A; Landi ML; Sarnacchiaro F; Facciolli G; Lombardi G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2777-80. PubMed ID: 9709946
[TBL] [Abstract][Full Text] [Related]
51. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
Dawood MY; Jarrett JC; Choe JK
Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
[TBL] [Abstract][Full Text] [Related]
52. [Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine].
Forsbach G; Olivares F; Vázquez J; Güitrón A
Ginecol Obstet Mex; 1998 Apr; 66():170-2. PubMed ID: 9617019
[TBL] [Abstract][Full Text] [Related]
53. [Primary hypothyroidism presenting with amenorrhea, galactorrhea, hyperprolactinemia and enlarged pituitary].
Tadmor OP; Barr I; Diamant YZ
Harefuah; 1992 Jan; 122(2):76-8. PubMed ID: 1572562
[TBL] [Abstract][Full Text] [Related]
54. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
56. Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
Iyer P; Molitch ME
Endocr Pract; 2011; 17(3):e55-8. PubMed ID: 21324816
[TBL] [Abstract][Full Text] [Related]
57. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
[TBL] [Abstract][Full Text] [Related]
58. Hyperprolactinemia. Long-term effects of bromocriptine.
Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
[TBL] [Abstract][Full Text] [Related]
59. [Use of lysenyl-forte and methergoline in the therapy of hyperprolactinemic hypogonadism].
Mel'nichenko GA; Dedov II; Gitel' EP; Ilovaĭskaia IA
Probl Endokrinol (Mosk); 1991; 37(2):20-2. PubMed ID: 1857694
[TBL] [Abstract][Full Text] [Related]
60. [Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully].
Sapunar J; López JM; Huete I; Tagle R
Rev Med Chil; 1992 Feb; 120(2):168-73. PubMed ID: 1340555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]